Mother and her child

Priscilla has a history of complicated pregnancies due to preeclampsia, a rare but deadly complication of pregnancy that is characterized by high blood pressure and can only be fully reversed by delivering the baby.

But she is now a mother of two thanks to a new test administered by Dr. John Kingdom, Perinatologist and Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute. Mount Sinai is the first hospital in Canada to offer this new test, called the Placenta Growth Factor test – a breakthrough in managing preeclampsia.

“It tells us very specifically what the risk is so we can determine the right level of care. And if there is a real risk, as in Priscilla’s case, we can act quickly,” says Dr. Kingdom. Priscilla is among the first patients to benefit from this new test.